By integrating these criteria, we identified ten key proteins (Figure 2) (EGFR, ESR1, HIF1A, HSP90AA1, MAPK1, BCL2, STAT3, TP53, CASP3, and SRC) that play central roles in tumor progression and are therefore considered crucial therapeutic targets for rosemary-derived compounds. The gene discussed is TP53; the disease is neoplasm.